Felicia Cox, a pioneering nurse leader and former editor-in-chief of the British Journal of Pain, has died aged 60. She dedicated her career to advancing pain management through clinical innovation, international nursing collaboration, and evidence-based advocacy, leaving a lasting impact on how chronic pain is understood and treated within the UK’s National Health Service (NHS) and beyond.
Championing Pain Science Through Nursing Leadership
Felicia Cox spent over a decade as editor-in-chief of the British Journal of Pain, a peer-reviewed journal published in partnership with Sage Publishing and the British Pain Society. Under her leadership, the journal expanded its focus on multidisciplinary approaches to pain, emphasizing the biopsychosocial model and integrating patient-reported outcomes into clinical research. She was instrumental in elevating nursing voices in pain science, advocating for nurse-led interventions in both acute and chronic pain settings.
As a founder of the Pain Nurse Network—originally established for UK nurses and now active internationally—Cox fostered cross-border education and policy alignment in pain assessment and management. Her work helped standardize pain documentation practices across NHS trusts, contributing to earlier intervention and reduced reliance on high-dose opioids in non-cancer pain.
In Plain English: The Clinical Takeaway
- Chronic pain affects over 43% of people in the UK, and nurse-led care improves outcomes by ensuring consistent monitoring and patient empowerment.
- Effective pain management combines physical therapies, psychological support, and, when appropriate, carefully monitored medication—not opioids alone.
- Advocates like Felicia Cox helped shift clinical culture from treating pain as a symptom to recognizing it as a condition requiring coordinated, long-term care.
Bridging Clinical Practice and Health Policy
Cox’s influence extended beyond publishing into national guideline development. She contributed to NHS England’s Pain Management: Clinical Guideline updates, advocating for increased funding for community-based pain clinics and better training for primary care nurses in neuropathic pain assessment. Her efforts aligned with the 2021 NICE guideline (NG193) on chronic primary pain, which discourages initiation of opioids and recommends exercise, psychological therapies, and acupuncture as first-line options.
Internationally, through the Pain Nurse Network, Cox supported knowledge transfer between high-income and low-resource settings, promoting low-cost, high-impact strategies such as group-based self-management programs and telehealth follow-ups—models now being piloted in rural Australia and parts of sub-Saharan Africa.
“Felicia understood that pain isn’t just a biological signal—it’s shaped by social context, access to care, and cultural beliefs. Her legacy is in making pain management more humane, more equitable, and more firmly rooted in what patients actually experience.”
Geo-Epidemiological Impact: From Tasmania to Transnational Care
Born in Launceston, Tasmania, Cox began her nursing career in Australia before moving to the UK, where she spent most of her professional life. Her transnational perspective informed her advocacy for culturally sensitive pain assessment tools—particularly key in Indigenous populations, where pain expression may be underreported due to stoicism or mistrust of medical systems.
In Tasmania, where chronic pain prevalence exceeds national averages due to aging demographics and higher rates of musculoskeletal injury, Cox’s work indirectly supported initiatives like the Tasmanian Pain Management Pathway, which integrates general practitioners, physiotherapists, and clinical psychologists in stepped-care models. Similar frameworks now exist in NHS Lothian and NHS Greater Glasgow and Clyde, showing how her influence helped shape regional adaptations of national guidelines.
Funding for the British Journal of Pain during Cox’s tenure came primarily from institutional subscriptions and society grants, with no direct pharmaceutical sponsorship influencing editorial content—a fact she repeatedly emphasized to preserve scientific independence. The British Pain Society, which owns the journal, receives funding from membership fees, charitable trusts, and limited, transparently disclosed industry collaborations governed by strict conflict-of-interest policies.
Contraindications & When to Consult a Doctor
While Felicia Cox’s work focused on improving access to care, This proves essential to recognize that persistent pain warrants medical evaluation. Individuals experiencing pain lasting more than three months, especially when accompanied by unexplained weight loss, night sweats, or neurological symptoms like numbness or weakness, should seek prompt clinical assessment to rule out underlying conditions such as cancer, infection, or spinal compression.
Patients with a history of substance leverage disorder should consult a specialist before initiating any opioid therapy, even for short-term use, due to heightened risk of relapse. Similarly, older adults or those with liver or kidney impairment require dose adjustments and alternative therapies—such as topical NSAIDs or low-dose gabapentinoids—under close supervision, as emphasized in NHS prescribing guidelines.
Anyone noticing a sudden change in pain pattern, or pain that interferes with sleep, mobility, or mental health, should contact their GP or a pain specialist. Early intervention improves long-term function and reduces the risk of central sensitization, where the nervous system becomes hypersensitive to stimuli.
“The greatest danger in pain management isn’t overtreatment—it’s under-recognition. Felicia spent her career ensuring that no patient’s pain was dismissed as ‘all in their head.’ That vigilance saves lives.”
The Legacy of Evidence-Based Advocacy
Felicia Cox’s career exemplifies the vital role of nurses not only as caregivers but as knowledge translators, editors, and system changers. By grounding her advocacy in peer-reviewed research and clinical experience, she helped shift pain management from a biomedical afterthought to a central component of quality healthcare.
Her work continues to influence current efforts to reduce opioid dependence, expand access to non-pharmacological therapies, and train the next generation of nurses in pain assessment—a mission now carried forward by the British Pain Society, the Faculty of Pain Medicine of the Royal College of Anaesthetists, and global networks she helped build.
References
- Williams AC de C, Eccleston C, Morley S. Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database Syst Rev. 2020;(2):CD007407. Doi:10.1002/14651858.CD007407.pub4.
- National Institute for Health and Care Excellence (NICE). Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain. NG193. Published April 2021.
- British Pain Society. British Journal of Pain. SAGE Journals. ISSN 2049-4637.
- Nicholas MK, et al. Group cognitive behavioural therapy for chronic low-back pain: a randomized controlled trial. Pain. 2009;142(3):260-6. Doi:10.1016/j.pain.2009.01.010.
- World Health Organization (WHO). Guidelines for the management of conditions specifically related to stress. 2023. Https://www.who.int/publications/i/item/9789240063987
